Back
Carlisle Companies 10K Form
Buy
52
CSL
Carlisle Companies
Last Price:
$346.76
Seasonality Move:
6.43%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2023-10-27 | 10Q | CSL/Carlisle Companies Quarterly |
2023-07-27 | 10Q | CSL/Carlisle Companies Quarterly |
2023-04-28 | 10Q | CSL/Carlisle Companies Quarterly |
2022-10-28 | 10Q | CSL/Carlisle Companies Quarterly |
2022-07-28 | 10Q | CSL/Carlisle Companies Quarterly |
2022-04-29 | 10Q | CSL/Carlisle Companies Quarterly |
Receive CSL News And Ratings
See the #1 stock for the next 7 days that we like better than CSL
CSL Financial Statistics
Sales & Book Value
Annual Sales: | $5B |
---|---|
Cash Flow: | $334M |
Price / Cash Flow: | 17.93 |
Annual Sales: | $55.48 |
Price / Book: | 6.32 |
Profitability
EPS (TTM): | 27.63000 |
---|---|
Net Income (TTM): | $1.3B |
Gross Margin: | $1.9B |
Return on Equity: | 47.12% |
Return on Assets: | 20.31% |
Carlisle Companies Earnings Forecast
Key Carlisle Companies Financial Ratios
-
The Gross Profit Margin over the past 41 years for CSL is 37.73%.
-
The Selling, General & Administrative Expenses for CSL have been equal to 12.29% of Gross Profit Margin.
-
The Research & Development expenses have been 0.71% of Revenue.
-
The Interest Expense is 5.59% of Operating Income.
-
The Net Earning history of CSL is 26.22% of Total Revenues.
-
Per Share Earnings over the last 41 years have been positive in 25 years.
Carlisle Companies Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Building Products |
Sector: | Industrials |
Current Symbol: | CSL |
CUSIP: | 142339 |
Website: | carlisle.com |
Debt
Debt-to-Equity Ratio: | 0.77 |
---|---|
Current Ratio: | 2.89 |
Quick Ratio: | 2 |
Price-to-Earnings
Trailing P/E Ratio: | 12.55 |
---|---|
Forward P/E Ratio: | 13.88 |
CSL Technical Analysis vs Fundamental Analysis
Buy
52
Carlisle Companies (CSL)
is a Buy
Is Carlisle Companies a Buy or a Sell?
-
Carlisle Companies stock is rated a BuyThe current Carlisle Companies [CSL] share price is $349.15. The Score for CSL is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.